Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, Johnson IT, Narbad A.

BMC Gastroenterol. 2010 Nov 12;10:134. doi: 10.1186/1471-230X-10-134.

2.

Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls.

Vigsnæs LK, Brynskov J, Steenholdt C, Wilcks A, Licht TR.

Benef Microbes. 2012 Dec 1;3(4):287-97. doi: 10.3920/BM2012.0018.

PMID:
22968374
3.

Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome.

Kerckhoffs AP, Ben-Amor K, Samsom M, van der Rest ME, de Vogel J, Knol J, Akkermans LM.

J Med Microbiol. 2011 Feb;60(Pt 2):236-45. doi: 10.1099/jmm.0.022848-0. Epub 2010 Oct 14.

PMID:
20947663
4.

Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome.

Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A.

J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.

PMID:
21761941
5.

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

Mättö J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M.

FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):213-22.

6.

Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria.

Maukonen J, Satokari R, Mättö J, Söderlund H, Mattila-Sandholm T, Saarela M.

J Med Microbiol. 2006 May;55(Pt 5):625-33.

PMID:
16585652
7.

Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.

Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, Mättö J, Mäkelä L, Palva A.

World J Gastroenterol. 2009 Dec 21;15(47):5936-45.

8.

Molecular characterisation of the faecal microbiota in patients with type II diabetes.

Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X, Yu P, Zhao C, Li L, Zhou A, Wang J, Moore JE, Millar BC, Xu J.

Curr Microbiol. 2010 Jul;61(1):69-78. doi: 10.1007/s00284-010-9582-9. Epub 2010 Jan 20.

PMID:
20087741
9.

Microbial community and metabolomic comparison of irritable bowel syndrome faeces.

Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH.

J Med Microbiol. 2011 Jun;60(Pt 6):817-27. doi: 10.1099/jmm.0.028126-0. Epub 2011 Feb 17.

10.

Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.

Shukla R, Ghoshal U, Dhole TN, Ghoshal UC.

Dig Dis Sci. 2015 Oct;60(10):2953-62. doi: 10.1007/s10620-015-3607-y. Epub 2015 Mar 18.

PMID:
25784074
11.

Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.

Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Mäkivuokko H, Kajander K, Palva A.

BMC Gastroenterol. 2009 Dec 17;9:95. doi: 10.1186/1471-230X-9-95.

12.

Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.

Chassard C, Dapoigny M, Scott KP, Crouzet L, Del'homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, Dubray C, Flint HJ, Bernalier-Donadille A.

Aliment Pharmacol Ther. 2012 Apr;35(7):828-38. doi: 10.1111/j.1365-2036.2012.05007.x. Epub 2012 Feb 8.

13.
14.

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.

Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F, Verbeke K, Ferrante M, Verhaegen J, Rutgeerts P, Vermeire S.

Gut. 2014 Aug;63(8):1275-83. doi: 10.1136/gutjnl-2013-304833. Epub 2013 Sep 10.

PMID:
24021287
15.

Fecal microbiota in pouchitis and ulcerative colitis.

Li KY, Wang JL, Wei JP, Gao SY, Zhang YY, Wang LT, Liu G.

World J Gastroenterol. 2016 Oct 28;22(40):8929-8939.

16.

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.

Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, Störsrud S, Le Nevé B, Öhman L, Simrén M.

Gastroenterology. 2017 Jan;152(1):111-123.e8. doi: 10.1053/j.gastro.2016.09.049. Epub 2016 Oct 7.

17.

Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis.

Zhong W, Lu X, Shi H, Zhao G, Song Y, Wang Y, Zhang J, Jin Y, Wang S.

J Clin Gastroenterol. 2017 Nov 28. doi: 10.1097/MCG.0000000000000961. [Epub ahead of print]

PMID:
29210899
18.

A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR.

Dig Dis Sci. 2010 Feb;55(2):392-7. doi: 10.1007/s10620-009-0934-x. Epub 2009 Aug 20.

PMID:
19693670
19.

Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.

Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A.

Am J Gastroenterol. 2005 Feb;100(2):373-82.

PMID:
15667495
20.

Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.

Andrews CN, Griffiths TA, Kaufman J, Vergnolle N, Surette MG, Rioux KP.

Aliment Pharmacol Ther. 2011 Aug;34(3):374-83. doi: 10.1111/j.1365-2036.2011.04732.x. Epub 2011 Jun 14.

Supplemental Content

Support Center